Katy Tobin

Dr. Katy Tobin

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2014 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
JRJames Rooney
James Rooney
SBSusan Byrne
Susan Byrne
MHMark Heverin
Mark Heverin
KTKaty Tobin
Katy Tobin
ADAlison Dick
Alison Dick
OHOrla Hardiman
Orla Hardiman
Background Amyotrophic lateral sclerosis (ALS) is a progressive debilitating neurodegenerative disease, with a life expectancy of 3–5 years from first symptom. There is compelling evidence that those who attend a multidisciplinary clinic experience improved survival. The purpose of the study was to explore the survival of patients with ALS ascertained through population-based Registers in the Republic of Ireland (RoI) and Northern Ireland (NI), and to determine whether centralisation of services confers advantage compared with community-based care supported by a specialist care worker. Methods The island of Ireland is divided into two countries, RoI and NI, each with an independent healthcare system. Both countries have population-based ALS Registers with full ascertainment. Data from all 719 incident ALS cases from Ireland and NI, diagnosed between 1 January 2005 and 31 December 2010, were used in the analysis. Results A survival benefit was identified for patients who attended the multidisciplinary ALS clinic in the RoI. (HR 0.59, 95% CI 0.49 to 0.71, p<0.001). This difference was preserved following multivariate analysis. A trend towards improved survival was noted for patients with ALS from NI when compared with RoI patients who did not attend a multidisciplinary clinic. Conclusions Centralised multidisciplinary care confers a survival advantage for patients with ALS and is superior to devolved community-based care. We propose that multiple decision-making processes within a multidisciplinary setting lead to an enriched set of clinical encounters for the patient and carer that enhances clinical outcome.

13 June 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
JRJames P.K. Rooney
James P.K. Rooney
CBCarol Brayne
Carol Brayne
KTKaty Tobin
Katy Tobin
GLGiancarlo Logroscino
Giancarlo Logroscino
MGM. Maria Glymour
M. Maria Glymour
OHOrla Hardiman
Orla Hardiman
Population-based disease registers identify and characterize all cases of disease, including those that might otherwise be neglected. Prospective population-based registers in neurodegeneration are necessary to provide comprehensive data on the whole phenotypic spectrum and can guide planning of health services. With the exception of the rare disease amyotrophic lateral sclerosis, few complete population-based registers exist for neurodegenerative conditions. Incomplete ascertainment, limitations and uncertainty in diagnostic categorization, and failure to recognize sources of bias reduce the accuracy and usefulness of many registers. Common biases include population stratification, the use of prevalent rather than incident cases in earlier years, changes in disease understanding and diagnostic criteria, and changing demographics over time. Future registers are at risk of funding shortfalls and changes to privacy legislation. Notwithstanding, as heterogeneities of clinical phenotype and disease pathogenesis are increasingly recognized in the neurodegenerations, well-designed longitudinal population-based disease registers will be an essential requirement to complete clinical understanding of neurodegenerative diseases.

2 February 2018 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
TBTom Burke
Tom Burke
OHOrla Hardiman
Orla Hardiman
MPMarta Pinto-Grau
Marta Pinto-Grau
KLKatie Lonergan
Katie Lonergan
MHMark Heverin
Mark Heverin
NPNiall Pender
Niall Pender

2 October 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
TMTriona McNicholas
Triona McNicholas
KTKaty Tobin
Katy Tobin
DCDaniel Carey
Daniel Carey
SOSusan O'CAllaghan
Susan O'CAllaghan
RKRose Anne Kenny
Rose Anne Kenny
Background: It is postulated that orthostatic hypotension ( OH ), a reduction in blood pressure (≥20/10 mm Hg) within 3 minutes of standing, may increase cognitive decline because of cerebral hypoperfusion. This study assesses the impact of OH on global cognition at 4‐year follow‐up, and the impact of age and hypertension on this association. Methods and Results: Data from waves 1 and 3 of TILDA (The Irish Longitudinal Study on Ageing) were used. Baseline blood pressure response to active stand was assessed using beat‐to‐beat blood pressure monitoring. Two measures of OH were used—at 40 seconds ( OH 40) and 110 seconds ( OH 110). Global cognition was measured using the Montreal Cognitive Assessment. Mixed‐effects Poisson regression assessed whether baseline OH was associated with a decline in global cognition at 4‐year follow‐up. The analysis was repeated, stratifying by age (age 50–64 years and age ≥65 years), and including an interaction between OH and hypertension. Baseline OH 110 was associated with an increased error rate in Montreal Cognitive Assessment at follow‐up (incident rate ratio 1.17, P =0.028). On stratification by age, the association persists in ages 50 to 64 years (incident rate ratio 1.25, P =0.048), but not ages ≥65 years. Including an interaction with hypertension found those with co‐existent OH 110 and hypertension (incident rate ratio 1.27, P =0.011), or OH 40 and hypertension (incident rate ratio 1.18, P =0.017), showed an increased error rate; however, those with isolated OH 110, OH 40, or isolated hypertension did not. Conclusions: OH is associated with a decline in global cognition at 4‐year follow‐up, and this association is dependent on age and co‐existent hypertension.

16 January 2018 in International Psychogeriatrics
Verified
Journal Article
Open access
PDF file
RBRobert Briggs
Robert Briggs
KTKaty Tobin
Katy Tobin
RKRose Anne Kenny
Rose Anne Kenny
SKSean P Kennelly
Sean P Kennelly
Objective:Late life depression (LLD) confers significant morbidity and mortality but is well recognized that it often goes undetected or untreated. The objective of this study is to quantify the burden of untreated depression and death ideation (DI) at a population level.Design:Cross-sectional study ascertaining the prevalence of, and factors associated with, untreated depression and DI.Setting:This study, embedded within the Irish Longitudinal Study on Ageing, involves over 7,000 community-dwelling people aged ≥50 years.Measurements:Depression was defined as Centre for Epidemiological Studies Depression scale ≥16 indicating current clinically relevant depressive symptoms or Composite International Diagnostic Interview indicative of major depressive episode within the last year. Participants not prescribed antidepressants/antipsychotics were defined as untreated. To define DI, participants were asked “In the last month, have you felt like you would rather be dead?”Results:In total, 12% (839/7,055) met criteria for depression with 29% (241/839) on pharmacological therapy. Those with untreated depression were less likely to endorse symptoms of persistent low mood or worthlessness, but there was no difference in age or general practitioner (GP) visits compared to those on treatment. Over 3% (223/7,055) of participants had DI and less than one-third had visited their GP within the last year.Conclusions:This study demonstrates that two-thirds of depressed older people are not prescribed antidepressant/antipsychotic therapy. It is important to raise awareness of depression among older people and healthcare professionals, with particular focus on the fact that LLD is not an inevitable consequence of ageing and effective treatment is available.

2 July 2016 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
KTKaty Tobin
Katy Tobin
MGMark S. Gilthorpe
Mark S. Gilthorpe
JRJames Rooney
James Rooney
MHMark Heverin
Mark Heverin
AVAlice Vajda
Alice Vajda
OHOrla Hardiman
Orla Hardiman